Schur Flexibles Gruppe

The company

The Schur Flexibles Group, headquarted in Baden, Austria is a European market leader in the flexible packaging industry. The company was created over the past five years by capiton and the CEO and co-owner Jakob A. Mosser, in the context of a buy-and-build concept.

Today, the group consists of twelve companies with eleven production sites in Germany, Finland, Denmark, Holland, Poland, Slovakia and Greece. In 2015, the group generated sales of almost € 370 million and employed more than 1100 staff.

The product portfolio of the company consists of specialized high value added flexible packaging solutions for the food, tobacco and pharmaceutical markets. The company also covers the entire value chain of the packaging industry, from raw material sourcing to extrusion, printing, lamination and converting.

The transaction

capiton acquired the first company of the group, CFS Dixie GmbH, in December 2011. The nucleus of the group was then purchased in early 2012 with the take-over of the Schur Flexibles Division (four companies) from Schur International (Denmark). Five further businesses were acquired until the end of 2014 to create the Flexibles business that exists today. In 2014 PS Polymer Sourcing, Warburg Germany was founded as an additional separate business unit.

As part of the share sale signed now, the shareholders of Schur Flexibles have sold their shareholdings to Lindsay Goldberg, represented in Europe by Lindsay Goldberg Vogel, and the management team. The new owners intend to continue the successful buy and build concept through the acquisition of further target companies, some of which have already been identified.

The transaction is still subject to the approval of the antitrust authorities. The parties have also agreed not to disclosure further details of the transaction.

capiton was advised by MP Corporate Finance (M&A), Kirkland & Ellis (Legal) und Deloitte (Financial).

Pressemitteilungen

capiton portfolio company Wundex is pleased to announce the acquisition of ELLIPSA, a wound care specialist with headquarters in Regensburg (Bavaria) and a second center of operations in Munich. In addition to the provision of wound care services and the wholesale supply of medical products, ELLIPSA has developed a proprietary digital education and training platform […]

capiton portfolio company Cedes is proud to announce the acquisition of the Vitector portfolio from Fraba, securing a leading position in the industrial door sensor market. As a global leader in elevator sensors, Cedes successfully applied its technology expertise and power of innovation to gain a foothold in the industrial door market, providing ultra-reliable safeguarding […]

Asyril SA, headquartered in Villaz-St-Pierre in Switzerland with subsidiaries in the US and Japan, is a market and technology leader in the flexible part feeder market. Its products are being used globally in assembly lines, facilitating process automation for a variety of industries.   Asyril’s product portfolio covers flexible feeding systems based on a patented […]

AlphaPet Ventures has started to implement its international expansion strategy with the acquisition of Arden Grange, a leading UK brand in the premium dog food segment. Family-run Arden Grange pioneered the category of species-appropriate dog food in the UK more than 25 years ago. Customers appreciate especially the high quality of the products, which aim […]

We are delighted to announce the successful acquisition of Stuga Machinery by our portfolio company Stürtz Group.   Stuga Machinery Limited, a market leading manufacturer of PVC sawing and machining centres to the UK and Ireland windows and doors industry, has been acquired by Stürtz Group. All of Stuga’s Directors and staff are continuing with […]

We are delighted to announce that our portfolio company EVP Group is combining forces with Vitafy Brands. Founded in Munich in 2014, Vitafy Brands has grown to be a leading consumer health D2C online platform for its own brands focusing on the development and offering of functional Consumer Health OTC products for health focused customers. […]

capiton acquires a majority stake in the Betonbau Group alongside its experienced management team, Mr. Volker Ernst and Mr. Thomas Sachers, from the SCHWENK Group in a carve-out transaction. Betonbau Group, headquartered in Waghäusel, Germany, was established in 1963. The name “Betonbau” goes back to its foundations when the company focused on the production of […]

capiton successfully closes fund VI at €504 million Largest fund in the company’s history Approximately €260 million, including co-investment, already deployed in seven portfolio companies Fund to continue successful deployment in capiton’s focus sectors Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption   Berlin, 24 November 2021 – capiton AG (“capiton”), a leading owner-managed private […]

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service […]